Yingxi Xu

2.9k total citations · 1 hit paper
77 papers, 2.0k citations indexed

About

Yingxi Xu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yingxi Xu has authored 77 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 33 papers in Oncology and 24 papers in Immunology. Recurrent topics in Yingxi Xu's work include CAR-T cell therapy research (24 papers), Immune Cell Function and Interaction (20 papers) and Acute Myeloid Leukemia Research (10 papers). Yingxi Xu is often cited by papers focused on CAR-T cell therapy research (24 papers), Immune Cell Function and Interaction (20 papers) and Acute Myeloid Leukemia Research (10 papers). Yingxi Xu collaborates with scholars based in China, United States and Switzerland. Yingxi Xu's co-authors include Rong Xiang, Na Li, Peiqing Sun, Jianxiang Wang, Qing Rao, Kejing Tang, Haiyan Xing, Tian Zheng, Min Wang and Yanan Chen and has published in prestigious journals such as Blood, PLoS ONE and Hepatology.

In The Last Decade

Yingxi Xu

72 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alistipes indistinctus-derived hippuric acid promotes intestinal urate excretion to alleviate hyperuricemia

2024 56 citations Yingxi Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yingxi Xu China	24	943	879	570	294	191	77	2.0k
Marco Genua Italy	24	1.0k 1.1×	1.2k 1.4×	724 1.3×	272 0.9×	397 2.1×	37	2.7k
Gerold Untergasser Austria	29	1.1k 1.2×	527 0.6×	280 0.5×	370 1.3×	165 0.9×	84	2.4k
Michaela Schlederer Austria	21	892 0.9×	767 0.9×	289 0.5×	323 1.1×	139 0.7×	40	1.9k
Shunsuke Uehara Japan	23	1.8k 1.9×	753 0.9×	277 0.5×	225 0.8×	341 1.8×	52	2.7k
Young Woo Eom South Korea	26	1.3k 1.4×	530 0.6×	356 0.6×	353 1.2×	111 0.6×	72	3.0k
Yasuo Kokai Japan	28	1.0k 1.1×	618 0.7×	374 0.7×	239 0.8×	139 0.7×	85	2.4k
Ke Guo China	28	2.1k 2.2×	457 0.5×	514 0.9×	565 1.9×	137 0.7×	68	3.1k
Robin C. Muise‐Helmericks United States	22	1.0k 1.1×	411 0.5×	234 0.4×	253 0.9×	104 0.5×	40	1.7k
Reiko Kato Japan	24	1.8k 1.9×	509 0.6×	406 0.7×	289 1.0×	366 1.9×	54	2.6k
Pei Shu China	12	528 0.6×	499 0.6×	559 1.0×	152 0.5×	236 1.2×	37	1.4k

Countries citing papers authored by Yingxi Xu

Since Specialization

Citations

This map shows the geographic impact of Yingxi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingxi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingxi Xu more than expected).

Fields of papers citing papers by Yingxi Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingxi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingxi Xu. The network helps show where Yingxi Xu may publish in the future.

Co-authorship network of co-authors of Yingxi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingxi Xu. A scholar is included among the top collaborators of Yingxi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingxi Xu. Yingxi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Shuai, Ping Wu, Yanpeng Liu, et al.. (2025). MSR1+ macrophages passivate antitumor immunity by inducing ITM2A+ CD4T exhaustion differentiation. Hepatology.

Xing, Haiyan, Wenbing Liu, Runxia Gu, et al.. (2025). U2AF1 mutation causes an oxidative stress and DNA repair defect in hematopoietic and leukemic cells. Free Radical Biology and Medicine. 228. 379–391.

Ma, Kaili, Yingxi Xu, Hongcheng Cheng, et al.. (2025). T cell-based cancer immunotherapy: opportunities and challenges. PubMed. 70(11). 1872–1890. 10 indexed citations

Yan, Zhifeng, Runxia Gu, Haotian Ma, et al.. (2024). A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells. Cellular Oncology. 47(5). 1879–1895. 6 indexed citations

Franco, Fabien, Alessio Bevilacqua, Kung‐Chi Kao, et al.. (2023). Regulatory circuits of mitophagy restrict distinct modes of cell death during memory CD8 ⁺ T cell formation. Science Immunology. 8(87). eadf7579–eadf7579. 22 indexed citations

Xu, Yingxi, et al.. (2023). Mitochondria Dictate Function and Fate of HSCs and T Cells. Cancer Immunology Research. 11(10). 1303–1313. 9 indexed citations

Zhang, Yu, Saisai Li, Ying Wang, et al.. (2022). A novel and efficient CD22 CAR-T therapy induced a robust antitumor effect in relapsed/refractory leukemia patients when combined with CD19 CAR-T treatment as a sequential therapy. Experimental Hematology and Oncology. 11(1). 15–15. 23 indexed citations

Xu, Yingxi, Qing Rao, Haiyan Xing, et al.. (2021). Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells. Blood Cancer Journal. 11(8). 144–144. 27 indexed citations

Shen, Jun, Yingxi Xu, Shuo Zhang, et al.. (2021). Single-cell transcriptome of early hematopoiesis guides arterial endothelial-enhanced functional T cell generation from human PSCs. Science Advances. 7(36). eabi9787–eabi9787. 18 indexed citations

10.

Xing, Haiyan, Xue Yang, Yingxi Xu, et al.. (2021). Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells. Cytotherapy. 23(9). 810–819. 23 indexed citations

11.

Xu, Yingxi, Tianhao Yu, Guojing Ma, et al.. (2021). Berberine modulates deacetylation of PPARγ to promote adipose tissue remodeling and thermogenesis via AMPK/SIRT1 pathway. International Journal of Biological Sciences. 17(12). 3173–3187. 69 indexed citations

12.

Yu, Tianhao, Lili Wen, Yingxi Xu, et al.. (2020). Fabrication and evaluation of an optimized acellular nerve allograft with multiple axial channels. Acta Biomaterialia. 115. 235–249. 29 indexed citations

13.

Li, Yihui, Zhe Liu, Huan Li, et al.. (2019). Mitochondrial dysfunction and oxidative stress in bone marrow stromal cells induced by daunorubicin leads to DNA damage in hematopoietic cells. Free Radical Biology and Medicine. 146. 211–221. 16 indexed citations

14.

Li, Saisai, Yingxi Xu, Jia Liu, et al.. (2018). CD33-Specific Chimeric Antigen Receptor T Cells with Different Co-Stimulators Showed Potent Anti-Leukemia Efficacy and Different Phenotype. Human Gene Therapy. 29(5). 626–639. 61 indexed citations

15.

Xu, Yingxi, Saisai Li, Ying Wang, et al.. (2018). Induced CD20 Expression on B-Cell Malignant Cells Heightened the Cytotoxic Activity of Chimeric Antigen Receptor Engineered T Cells. Human Gene Therapy. 30(4). 497–510. 22 indexed citations

16.

Liu, Jia, Wenting Lu, Shuang Liu, et al.. (2018). ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation. Leukemia Research. 68. 15–21. 11 indexed citations

17.

Xu, Yingxi, Jia Liu, Ying Wang, et al.. (2017). Regulatory T Cells Promote the Stemness of Acute Myeloid Leukemia Cells through IL10 Cytokine Related Signaling Pathway. Blood. 130. 2727–2727. 3 indexed citations

18.

Xu, Yingxi, Shu Zhang, Yujie Ye, et al.. (2015). STIM1 accelerates cell senescence in a remodeled microenvironment but enhances the epithelial-to-mesenchymal transition in prostate cancer. Scientific Reports. 5(1). 11754–11754. 43 indexed citations

19.

Xu, Yingxi, Na Li, Rong Xiang, & Peiqing Sun. (2014). Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. Trends in Biochemical Sciences. 39(6). 268–276. 216 indexed citations

20.

Huang, Jing, et al.. (2011). An auto-SCT-based total therapy resulted in encouraging outcomes in adolescents and young adults with acute lymphoblastic leukemia: report from a single center of China. Bone Marrow Transplantation. 47(8). 1087–1094. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact